Related Experiment Videos
Pharmacologic radionuclide myocardial perfusion imaging
Sachin M Navare1, Athanasios Kapetanopoulos, Gary V Heller
1University of Connecticut School of Medicine, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA.
Current Cardiology Reports
|December 21, 2002
Summary
Pharmacologic stress testing aids in diagnosing and assessing prognosis for coronary artery disease in patients unable to exercise. This method, using vasodilators or inotropes, offers high accuracy for detecting heart disease and stratifying cardiac event risk.
Area of Science:
- Cardiology
- Diagnostic Imaging
Background:
- Pharmacologic stress testing is crucial for evaluating coronary artery disease (CAD) in patients with exercise limitations.
- It utilizes pharmacological agents to induce cardiac stress, mimicking exercise effects.
Purpose of the Study:
- To review the diagnostic and prognostic applications of pharmacologic stress testing in coronary artery disease.
- To highlight its utility in risk stratification post-myocardial infarction and pre-operatively.
Main Methods:
- Review of current evidence on pharmacologic stress agents (vasodilators and inotropes).
- Analysis of sensitivity and specificity for CAD diagnosis.
- Evaluation of prognostic value for cardiac events.
Main Results:
- Pharmacologic stress testing demonstrates high sensitivity (89%-91%) and specificity (78%-86%) for CAD diagnosis.
- Risk stratification is based on the extent and severity of myocardial perfusion abnormalities.
- It enables early risk stratification after myocardial infarction and identifies high-risk surgical patients.
Conclusions:
- Pharmacologic stress testing is a valuable tool for diagnosing CAD and assessing prognosis in patients unable to exercise.
- It provides essential risk stratification for cardiac events, outperforming exercise stress testing in certain scenarios.